These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 28364259

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differential temporal effects of sclerostin antibody and parathyroid hormone on cancellous and cortical bone and quantitative differences in effects on the osteoblast lineage in young intact rats.
    Ominsky MS, Brown DL, Van G, Cordover D, Pacheco E, Frazier E, Cherepow L, Higgins-Garn M, Aguirre JI, Wronski TJ, Stolina M, Zhou L, Pyrah I, Boyce RW.
    Bone; 2015 Dec; 81():380-391. PubMed ID: 26261096
    [Abstract] [Full Text] [Related]

  • 5. Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.
    Li X, Ominsky MS, Warmington KS, Niu QT, Asuncion FJ, Barrero M, Dwyer D, Grisanti M, Stolina M, Kostenuik PJ, Simonet WS, Paszty C, Ke HZ.
    Endocrinology; 2011 Sep; 152(9):3312-22. PubMed ID: 21733832
    [Abstract] [Full Text] [Related]

  • 6. Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis.
    Li X, Ominsky MS, Villasenor KS, Niu QT, Asuncion FJ, Xia X, Grisanti M, Wronski TJ, Simonet WS, Ke HZ.
    Endocrinology; 2018 Jan 01; 159(1):260-271. PubMed ID: 29069393
    [Abstract] [Full Text] [Related]

  • 7. Tissue-level mechanisms responsible for the increase in bone formation and bone volume by sclerostin antibody.
    Ominsky MS, Niu QT, Li C, Li X, Ke HZ.
    J Bone Miner Res; 2014 Jun 01; 29(6):1424-30. PubMed ID: 24967455
    [Abstract] [Full Text] [Related]

  • 8. Sclerostin antibody treatment improves implant fixation in a model of severe osteoporosis.
    Virdi AS, Irish J, Sena K, Liu M, Ke HZ, McNulty MA, Sumner DR.
    J Bone Joint Surg Am; 2015 Jan 21; 97(2):133-40. PubMed ID: 25609440
    [Abstract] [Full Text] [Related]

  • 9. Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse.
    Zhang D, Hu M, Chu T, Lin L, Wang J, Li X, Ke HZ, Qin YX.
    Bone; 2016 Jun 21; 87():161-8. PubMed ID: 26868528
    [Abstract] [Full Text] [Related]

  • 10. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ, Bu SY, Wang Y, Rendina E, Lim YF, Marlow D, Clarke SL, Cullen DM, Lucas EA.
    Bone; 2014 Jan 21; 58():151-9. PubMed ID: 24125756
    [Abstract] [Full Text] [Related]

  • 11. Sclerostin antibody treatment causes greater alveolar crest height and bone mass in an ovariectomized rat model of localized periodontitis.
    Chen H, Xu X, Liu M, Zhang W, Ke HZ, Qin A, Tang T, Lu E.
    Bone; 2015 Jul 21; 76():141-8. PubMed ID: 25868799
    [Abstract] [Full Text] [Related]

  • 12. Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibody.
    Li X, Niu QT, Warmington KS, Asuncion FJ, Dwyer D, Grisanti M, Han CY, Stolina M, Eschenberg MJ, Kostenuik PJ, Simonet WS, Ominsky MS, Ke HZ.
    Endocrinology; 2014 Dec 21; 155(12):4785-97. PubMed ID: 25259718
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combined treatment with parathyroid hormone (1-34) and beta-tricalcium phosphate had an additive effect on local bone formation in a rat defect model.
    Tao ZS, Tu KK, Huang ZL, Zhou Q, Sun T, Xu HM, Zhou YL, Lv YX, Cui W, Yang L.
    Med Biol Eng Comput; 2016 Sep 21; 54(9):1353-62. PubMed ID: 26429350
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sclerostin antibody and interval treadmill training effects in a rodent model of glucocorticoid-induced osteopenia.
    Achiou Z, Toumi H, Touvier J, Boudenot A, Uzbekov R, Ominsky MS, Pallu S, Lespessailles E.
    Bone; 2015 Dec 21; 81():691-701. PubMed ID: 26409255
    [Abstract] [Full Text] [Related]

  • 18. Sclerostin antibody stimulates bone regeneration after experimental periodontitis.
    Taut AD, Jin Q, Chung JH, Galindo-Moreno P, Yi ES, Sugai JV, Ke HZ, Liu M, Giannobile WV.
    J Bone Miner Res; 2013 Nov 21; 28(11):2347-56. PubMed ID: 23712325
    [Abstract] [Full Text] [Related]

  • 19. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
    Meng XW, Liang XG, Birchman R, Wu DD, Dempster DW, Lindsay R, Shen V.
    J Bone Miner Res; 1996 Apr 21; 11(4):421-9. PubMed ID: 8992872
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.